Jagsonpal Pharmaceuticals
₹242.40
3
-₹0.62-0.26% Friday 09:59
Statistics
Day High
242.4
Day Low
241.98
52W High
264.5
52W Low
155
Volume
1,652
Avg. Volume
-
Mkt Cap
16.23B
P/E Ratio
36.46
Dividend Yield
1.65%
Dividend
4
Upcoming
Dividends
1.65%Dividend Yield
Sep 26
₹4.00
Sep 25
₹2.50
Sep 24
₹2.00
Aug 23
₹2.00
Nov 21
₹1.60
10Y Growth
51.21%
5Y Growth
65.72%
3Y Growth
7.72%
1Y Growth
25%
Earnings
21MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A
Financials
15.2%Profit Margin
Profitable4.37BRevenue
664.51MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow JAGSNPHARM.NSE. It's not an investment recommendation.
Bhansali Engineering Polymers
2
BEPL.NSE
KNR Constructions
2
KNRCON.NSE
NIIT
2
NIITLTD.NSE
Parag Milk Foods
2
PARAGMILK.NSE
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Jagsonpal Pharmaceuticals Limited, an Indian company founded in 1964 and based in New Delhi, specializes in the development and manufacturing of both bulk active pharmaceutical ingredients and diverse medicinal formulations. Its product portfolio spans three primary therapeutic domains: women's health, pain management and analgesia, and general medical care. Within general medicine, the company offers solutions for allergy control, immune and cellular protection, gastrointestinal and mental wellness, anti-infectives, and products specifically for dental and ear, nose, and throat (ENT) conditions. For women's healthcare, their offerings include pregnancy support and treatments for issues related to dysfunctional uterine bleeding. Furthermore, Jagsonpal provides medications for pain relief and skeletal and joint health. These pharmaceutical items are supplied in common forms like tablets, capsules, and syrups. The company operates as a subsidiary under Aresko Progressive Private Limited.
Show more...
CEO
Manish Gupta
Employees
1399
Country
India
ISIN
INE048B01035
Listings
0 Comments
Share your thoughts
FAQ
What is Jagsonpal Pharmaceuticals stock price today?▼
The current price of JAGSNPHARM.NSE is ₹242.40 INR — it has decreased by -0.26% in the past 24 hours. Watch Jagsonpal Pharmaceuticals stock price performance more closely on the chart.
What is Jagsonpal Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on NSE (India) exchange Jagsonpal Pharmaceuticals stocks are traded under the ticker JAGSNPHARM.NSE.
Is Jagsonpal Pharmaceuticals stock price growing?▼
JAGSNPHARM.NSE stock has risen by +1.4% compared to the previous week, the month change is a +1% rise, over the last year Jagsonpal Pharmaceuticals has showed a +1% increase.
What is Jagsonpal Pharmaceuticals market cap?▼
Today Jagsonpal Pharmaceuticals has the market capitalization of 16.23B
What is Jagsonpal Pharmaceuticals revenue for the last year?▼
Jagsonpal Pharmaceuticals revenue for the last year amounts to 4.37B INR.
What is Jagsonpal Pharmaceuticals net income for the last year?▼
JAGSNPHARM.NSE net income for the last year is 664.51M INR.
Does Jagsonpal Pharmaceuticals pay dividends?▼
Yes, JAGSNPHARM.NSE dividends are paid annual. The last dividend per share was 2.5 INR. As of today, Dividend Yield (FWD)% is 1.65%.
How many employees does Jagsonpal Pharmaceuticals have?▼
As of September 05, 2026, the company has 1,399 employees.
In which sector is Jagsonpal Pharmaceuticals located?▼
Jagsonpal Pharmaceuticals operates in the Health & Wellness sector.
When did Jagsonpal Pharmaceuticals complete a stock split?▼
The last stock split for Jagsonpal Pharmaceuticals was on January 08, 2025 with a ratio of 2.5:1.
Where is Jagsonpal Pharmaceuticals headquartered?▼
Jagsonpal Pharmaceuticals is headquartered in Gurugram, India.